Section Arrow
CGEM.NASDAQ
- Cullinan Therapeutics
Quotes are at least 15-min delayed:2024/05/14 22:58 EDT
Last
 26.38
+0.25 (+0.96%)
Day High 
27.33 
Prev. Close
26.13 
1-M High
30.1886 
Volume 
641.50K 
Bid
25.1
Ask
26.63
Day Low
26.14 
Open
26.17 
1-M Low
15.2 
Market Cap 
1.13B 
Currency USD 
P/E -- 
%Yield
10-SMA 27.64 
20-SMA 23.41 
50-SMA 19.47 
52-W High 30.1886 
52-W Low 7.64 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.69/-2.52
Enterprise Value
1.13B
Balance Sheet
Book Value Per Share
10.54
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8628+0.0221+2.63%-- 
JAGXJaguar Health0.2749-0.0154-5.30%-- 
NVAXNovavax13.48+0.37+2.82%-- 
SCPXScorpius Holdings0.0768-0.1047-57.69%-- 
RXRXRecursion Pharmaceuticals10.05+0.57+6.01%-- 
Quotes are at least 15-min delayed:2024/05/14 22:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancerand autoimmune indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.